Who owns Akebia Therapeutics?
- Ticker: AKBA
- CUSIP Number: 00972d105
Tip: Access positions for across all investors
Analyze quarterly positions in Akebia Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Akebia Therapeutics stock
Who bought or sold Akebia Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Satter Management | 13M | $24M | -19% | Mar 2024 |
|
| Vanguard Group | 8.2M | $15M | 8% | Mar 2024 |
|
| Acadian Asset Management | 5.3M | $9.7M | -26% | Mar 2024 |
|
| Millennium Management | 3.3M | $6.0M | 26% | Mar 2024 |
|
| Susquehanna International | 2.7M | $4.9M | 156% | Mar 2024 |
|
| BlackRock | 2.5M | $4.6M | 3% | Mar 2024 |
|
| Qube Research & Technologies | 2.3M | $4.1M | 1764% | Mar 2024 |
|
| Geode Capital Management | 1.8M | $3.3M | 5% | Mar 2024 |
|
| Jacobs Levy Equity Management | 1.6M | $3.0M | -12% | Mar 2024 |
|
| Goldman Sachs Group | 1.4M | $2.6M | 1885% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 1.0M | $1.9M | 68% | Mar 2024 |
|
| Marshall Wace | 1.0M | $1.9M | 100% | Mar 2024 |
|
| Federated Investors | 867k | $1.1M | -10% | Dec 2023 |
|
| Assenagon Asset Management | 791k | $1.4M | 100% | Mar 2024 |
|
| Morgan Stanley | 788k | $1.4M | 91% | Mar 2024 |
|
| FMR | 503k | $921k | -21% | Mar 2024 |
|
| Eudaimonia Asset Management | 429k | $784k | 100% | Mar 2024 |
|
| Citadel Advisors | 424k | $777k | -2% | Mar 2024 |
|
| Cubist Systematic Strategies | 398k | $729k | 489% | Mar 2024 |
|
| Jane Street | 398k | $728k | 308% | Mar 2024 |
|
| Bank of America Corporation | 356k | $651k | 60% | Mar 2024 |
|
| Northern Trust | 334k | $612k | 11% | Mar 2024 |
|
| Marathon Trading Investment Management | 260k | $476k | 100% | Mar 2024 |
|
| Squarepoint Ops | 255k | $466k | 733% | Mar 2024 |
|
| Boothbay Fund Management | 240k | $439k | 100% | Mar 2024 |
|
| Barclays | 210k | $384k | 100% | Mar 2024 |
|
| Sapient Capital | 200k | $366k | 0% | Mar 2024 |
|
| Citigroup | 188k | $344k | -39% | Mar 2024 |
|
| Point72 Asia | 186k | $341k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 179k | $327k | 100% | Mar 2024 |
|
| Russell Investments | 176k | $322k | -3% | Mar 2024 |
|
| Two Sigma Advisers | 160k | $293k | -4% | Mar 2024 |
|
| Tudor Investment Corporation | 142k | $260k | 0% | Mar 2024 |
|
| Y-Intercept | 141k | $258k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 138k | $252k | 100% | Mar 2024 |
|
| Creative Planning | 111k | $203k | 0% | Mar 2024 |
|
| UBS Group | 99k | $182k | -37% | Mar 2024 |
|
| Gts Securities | 97k | $178k | 18% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 93k | $169k | 100% | Mar 2024 |
|
| Orchard Capital Managment | 87k | $108k | 30% | Dec 2023 |
|
| Brevan Howard Capital Management | 82k | $150k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 80k | $146k | 0% | Mar 2024 |
|
| HighTower Advisors | 73k | $135k | -24% | Mar 2024 |
|
| Wolverine Trading | 71k | $130k | 40% | Mar 2024 |
|
| Bank Of Montreal | 69k | $126k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 60k | $110k | 0% | Mar 2024 |
|
| CTC Alternative Strategies | 59k | $107k | 100% | Mar 2024 |
|
| Edmond De Rothschild Holding | 50k | $92k | 0% | Mar 2024 |
|
| CWA Asset Management | 49k | $90k | 0% | Mar 2024 |
|
| Deerfield Management Company | 47k | $86k | 100% | Mar 2024 |
|
| LMR Partners | 45k | $82k | 100% | Mar 2024 |
|
| Raymond James & Associates | 41k | $76k | 38% | Mar 2024 |
|
| TD Waterhouse Canada | 41k | $80k | 0% | Mar 2024 |
|
| Tower Research Capital | 35k | $63k | 2849% | Mar 2024 |
|
| Two Sigma Securities | 32k | $59k | 170% | Mar 2024 |
|
| Graham Capital Management | 29k | $53k | 22% | Mar 2024 |
|
| Cannon Global Investment Management | 28k | $51k | 100% | Mar 2024 |
|
| Wealth Effects | 27k | $49k | -8% | Mar 2024 |
|
| Eudaimonia Partners | 26k | $48k | -3% | Mar 2024 |
|
| Compass Ion Advisors | 25k | $46k | 100% | Mar 2024 |
|
| Mackenzie Financial | 25k | $45k | 7% | Mar 2024 |
|
| Polymer Capital Management | 24k | $44k | 100% | Mar 2024 |
|
| Leucadia National Corporation | 23k | $41k | 100% | Mar 2024 |
|
| Oxford Asset Management | 22k | $41k | 100% | Mar 2024 |
|
| Mercer Global Advisors | 22k | $41k | 13% | Mar 2024 |
|
| Commonwealth Equity Services | 22k | $40k | 18% | Mar 2024 |
|
| Independent Wealth Network | 22k | $7.2k | 100% | Mar 2024 |
|
| Victory Capital Management | 22k | $40k | -3% | Mar 2024 |
|
| Group One Trading | 21k | $38k | -77% | Mar 2024 |
|
| Bank of New York Mellon | 19k | $34k | -74% | Mar 2024 |
|
| LPL Financial | 18k | $33k | 100% | Mar 2024 |
|
| Willis Johnson & Associates | 18k | $32k | 0% | Mar 2024 |
|
| Envestnet Asset Management | 17k | $30k | 16% | Mar 2024 |
|
| James J. Burns & Company | 16k | $25k | -36% | Mar 2024 |
|
| Onyx Bridge Wealth Group | 15k | $20k | 20% | Mar 2024 |
|
| Sykon Capital | 15k | $28k | 0% | Mar 2024 |
|
| TradeLink Capital | 13k | $24k | 100% | Mar 2024 |
|
| Springbok Capital Management | 13k | $24k | 100% | Mar 2024 |
|
| Baird Financial | 13k | $16k | 0% | Dec 2023 |
|
| Symmetry Investments | 12k | $23k | 100% | Mar 2024 |
|
| Legacy Private Trust | 12k | $22k | 100% | Mar 2024 |
|
| Eagle Wealth Strategies | 12k | $20k | -40% | Mar 2024 |
|
| Bayesian Capital Management | 11k | $20k | 100% | Mar 2024 |
|
| Colony | 11k | $13k | 100% | Mar 2024 |
|
| Grimes & Company | 10k | $18k | 100% | Mar 2024 |
|
| Sonora Investment Management Group | 10k | $18k | 0% | Mar 2024 |
|
| RB Capital Management | 10k | $12k | 0% | Dec 2023 |
|
| ADAR1 Capital Management | 9.7k | $18k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 8.0k | $15k | -28% | Mar 2024 |
|
| Torno Capital | 5.8k | $11k | 100% | Mar 2024 |
|
| Ameliora Wealth Management | 5.6k | $10k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 4.9k | $9.0k | 0% | Mar 2024 |
|
| Fifth Third Bancorp | 3.3k | $6.0k | 0% | Mar 2024 |
|
| Headlands Technologies | 2.7k | $5.0k | 100% | Mar 2024 |
|
| Goss Wealth Management | 2.5k | $4.6k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 1.7k | $3.2k | 135% | Mar 2024 |
|
| Johnson Financial Group | 1.4k | $1.7k | 0% | Dec 2023 |
|
| CWM | 1.0k | $2.0k | 100% | Mar 2024 |
|
| Hanson McClain Advisors | 748.00 | $1.4k | 0% | Mar 2024 |
|
| Nbc Securities | 690.00 | $1.0k | 100% | Mar 2024 |
|
| Baldwin Brothers | 561.00 | $1.0k | 0% | Mar 2024 |
|
| Capital Advisors | 320.00 | $1.0k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 238.00 | $0 | 138% | Mar 2024 |
|
| Jpmorgan Chase & Co | 231.00 | $423.007200 | 0% | Mar 2024 |
|
| Hexagon Capital Partners | 186.00 | $340.008000 | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 171.00 | $312.998400 | -98% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 150.00 | $274.995000 | 100% | Mar 2024 |
|
| Atlantic Trust | 100.00 | $163.000000 | 100% | Mar 2024 |
|
Who sold out of Akebia Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Dec 2023 | 185k | $230k |
| XTX Topco | Sep 2023 | 139k | $158k |
| Mirabella Financial Services | Dec 2023 | 65k | $81k |
| Franklin Resources | Dec 2023 | 65k | $81k |
| Virtu Financial | Dec 2023 | 60k | $74k |
| Verition Fund Management | Sep 2023 | 56k | $64k |
| State of Wyoming | Dec 2023 | 40k | $49k |
| Schonfeld Strategic Advisors | Dec 2023 | 21k | $26k |
| Private Advisor | Dec 2023 | 20k | $25k |
| Archer Investment Corp | Dec 2023 | 20k | $25k |
| Hrt Financial | Dec 2023 | 15k | $18k |
| Ameritas Advisory Services | Sep 2023 | 12k | $11k |
| AdvisorNet Financial | Dec 2023 | 5.0k | $6.2k |